Mr. Schenk is a Director in Houlihan Lokey’s Financial Restructuring Group. He specializes in financial restructuring, liability management, special situations, and financing transactions. Mr. Schenk is based in the firm’s Los Angeles office.
Mr. Schenk has worked on many notable financial restructuring and liability management engagements across a variety of industries, including MultiPlan, Intelsat, Diebold Nixdorf, Erickson, Cumulus Media, Outcome Health (formerly Context Media), Millennium Health, 21st Century Oncology, Mallinckrodt Pharmaceuticals, Purdue Pharma, Endo Pharmaceuticals, SiO2 Material Science, and Ameritox.
Before joining Houlihan Lokey, Mr. Schenk was a member of the financial restructuring group of PwC, where he specialized in consulting for financially distressed companies as well as in valuations and due diligence related projects.
Mr. Schenk holds a B.A. in Finance from Utah State University and an M.S. in Economics from Utah State University’s Huntsman School of Business.